The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.
Open accessAbstract
T cells infiltrating inflammatory sites are usually of the activated/memory type. The precise mechanism for the positioning of these cells within tissues is unclear. Adhesion molecules certainly play a role; however, the intricate control of cell migration appears to be mediated by numerous chemokines and their receptors. Particularly important chemokines for activated/memory T cells are the CXCR3 ligands IP-10 and Mig and the CCR5 ligands RANTES, macrophage inflammatory protein-1alpha, and macrophage inflammatory protein-1beta. We raised anti-CXCR3 mAbs and were able to detect high levels of CXCR3 expression on activated T cells. Surprisingly, a proportion of circulating blood T cells, B cells, and natural killer cells also expressed CXCR3. CCR5 showed a similar expression pattern as CXCR3, but was expressed on fewer circulating T cells. Blood T cells expressing CXCR3 (and CCR5) were mostly CD45RO+, and generally expressed high levels of beta1 integrins. This phenotype resembled that of T cells infiltrating inflammatory lesions. Immunostaining of T cells in rheumatoid arthritis synovial fluid confirmed that virtually all such T cells expressed CXCR3 and approximately 80% expressed CCR5, representing high enrichment over levels of CXCR3+ and CCR5+ T cells in blood, 35 and 15%, respectively. Analysis by immunohistochemistry of various inflamed tissues gave comparable findings in that virtually all T cells within the lesions expressed CXCR3, particularly in perivascular regions, whereas far fewer T cells within normal lymph nodes expressed CXCR3 or CCR5. These results demonstrate that the chemokine receptor CXCR3 and CCR5 are markers for T cells associated with certain inflammatory reactions, particularly TH-1 type reactions. Moreover, CXCR3 and CCR5 appear to identify subsets of T cells in blood with a predilection for homing to these sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CCR5, another chemokine receptor with similar homing properties, has been also used to identify these cells [144, 145], but it is expressed only on the more differentiated Th1 effector memory population [146].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [145]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 7,009
Current Protocols in Immunology
(2018) · Current Protocols in Immunology · doi:10.1002/(issn)1934-368x · Cited by 3,574
Lymphocyte Homing and Homeostasis
Butcher, E. C., & Picker, L. J. (1996) · Science · doi:10.1126/science.272.5258.60 · Cited by 2,846
Baggiolini, M., Dewald, B., & Moser, B. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.675 · Cited by 2,193
Self-citationThe lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark‐Lewis, I., Sodroski, J., & Springer, T. A. (1996) · Nature · doi:10.1038/382829a0 · Cited by 1,953
Oberlin, E., Amara, A., Bachelerie, F., Chable-Bessia, C., Virelizier, J., Arenzana‐Seisdedos, F., Schwartz, O., Heard, J., Clark‐Lewis, I., Legler, D. F., et al. (1996) · Nature · doi:10.1038/382833a0 · Cited by 1,652
Self-citationA highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A., & Springer, T. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1101 · Cited by 1,482
Current protocols in immunology
Nezlin, R. S. (1992) · Molecular Immunology · doi:10.1016/0161-5890(92)90114-d · Cited by 1,413
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
Schall, T. J., Bacon, K. B., Toy, K. J., & Goeddel, D. V. (1990) · Nature · doi:10.1038/347669a0 · Cited by 1,378
Loetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1996) · Journal of Experimental Medicine · doi:10.1084/jem.184.3.963 · Cited by 1,333
Self-citation
Cited by
Sorted by citations
Items 501–600 of 1,000
Huffnagle, G. B., & McNeil, L. K. (1999) · Journal of NeuroVirology · doi:10.3109/13550289909029748 · Cited by 60
Kalayciyan, A., & Zouboulis, C. C. (2006) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2006.01863.x · Cited by 60
Cytokines and chemokines in the immune response to hepatitis C infection
Heydtmann, M., Shields, P. L., McCaughan, G. W., & Adams, D. (2001) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200106000-00006 · Cited by 60
Moore, B. B., Fry, C., Zhou, Y., Murray, S., Han, M. K., Martínez, F. J., Flaherty, K. R., & The COMET Investigators (2014) · Frontiers in Medicine · doi:10.3389/fmed.2014.00056 · Cited by 61
Yao, T., Kuo, M., See, L., Ou, L.-S., Lee, W., Chan, C., & Huang, J. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21962 · Cited by 59
Small Molecule CXCR3 Antagonists
Andrews, S. P., & Cox, R. J. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01337 · Cited by 60
I-TAC/CXCL11 is a natural antagonist for CCR5
Petkovic, V., Moghini, C., Paoletti, S., Uguccioni, M., & Gerber, B. O. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1103570 · Cited by 59
Chen, J., Vistica, B. P., Takase, H., Ham, D. I., Fariss, R. N., Wawrousek, E. F., Chan, C., DeMartino, J. A., Farber, J. M., & Gery, I. (2004) · European Journal of Immunology · doi:10.1002/eji.200425318 · Cited by 59
Kittang, A. O., Hatfield, K. J., Sand, K. E., Reikvam, H., & Bruserud, Ø. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_25 · Cited by 58
Karkada, M., Cordeiro, E., Vaci, M., McMaster, C. R., & Issekutz, T. B. (2005) · European Journal of Immunology · doi:10.1002/eji.200425885 · Cited by 58
Park, M., Jung, S., Yb, P., & Lee, S. (2008) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740801898608 · Cited by 58
Cohen, S. B., Maurer, K. J., Egan, C. E., Oghumu, S., Satoskar, A. R., & Denkers, E. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003706 · Cited by 58
Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats
Das, A., Guyton, M. K., Smith, A. W., Wallace, G., McDowell, M. L., Matzelle, D. D., Ray, S. K., & Banik, N. L. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12064 · Cited by 58
Coursey, T. G., Gandhi, N. B., Volpe, E. A., Pflugfelder, S. C., & de Paiva, C. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078508 · Cited by 58
Alpha-chemokine receptors CXCR1–3 and their ligands in idiopathic inflammatory myopathies
Paepe, B. D., Keyzer, K. D., Martin, J., & Bleecker, J. D. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-0989-5 · Cited by 58
Charles, P. C., Chen, X., Horwitz, M. S., & Brosnan, C. F. (1999) · Journal of NeuroVirology · doi:10.3109/13550289909029746 · Cited by 58
Azeez, S. S., Yashooa, R. K., Smail, S., Salihi, A., Ali, A. S., Mamand, S., & Janson, C. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02386-8 · Cited by 56
Pokkali, S., Das, S. D., & Logamurthy, R. (2008) · Cytokine · doi:10.1016/j.cyto.2007.12.009 · Cited by 57
Meyer, J., Harris, S. A., Satti, I., Poulton, I. D., Poyntz, H., Tanner, R., Rowland, R., Griffiths, K., Fletcher, H. A., & McShane, H. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.12.042 · Cited by 57
CXCR5 may be involved in the attraction of human metastatic neuroblastoma cells to the bone marrow
Airoldi, I., Cocco, C., Morandi, F., Prigione, I., & Pistoia, V. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0392-2 · Cited by 57
Genomic organization, sequence and transcriptional regulation of the human CXCL 11 gene
Tensen, C. P., Flier, J., Rampersad, S. S., Sampat-Sardjoepersad, S. C., Scheper, R. J., Boorsma, D. M., & Willemze, R. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00084-6 · Cited by 57
Roles of CCR2 and CXCR3 in the T cell–mediated response occurring during lupus flares
Amoura, Z., Combadière, C., Faure, S., Parizot, C., Miyara, M., Raphaël, D., Ghillani‐Dalbin, P., Debré, P., Pietté, J. C., & Gorochov, G. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11350 · Cited by 57
The role of chemokines and their receptors in dendritic cell biology
Lukacs‐Kornek, V. (2007) · Frontiers in bioscience · doi:10.2741/2838 · Cited by 63
Tissue trafficking patterns of effector memory CD4 T cells in rheumatoid arthritis.
Zhang, X., Nakajima, T., Goronzy, J. J., & Weyand, C. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21482 · Cited by 56
Lima, M., Leander, M., Santos, M., Santos, A. H., Lau, C., Queirós, M. L., Gonçalves, M. M. D. S. L. B., Fonseca, S., Moura, J., Teixeira, M. D. A., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/839684 · Cited by 56
Assessing Osteolysis with Use of High-Throughput Protein Chips
Shanbhag, A. S., Kaufman, A. M., Hayata, K., & Rubash, H. E. (2007) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-200705000-00022 · Cited by 56
Yamano, Y., & Coler-Reilly, A. L. G. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.08.012 · Cited by 56
T Cell Effector Subsets: Extending the Th1/Th2 Paradigm
Chtanova, T., & Mackay, C. R. (2001) · Advances in immunology · doi:10.1016/s0065-2776(01)78005-4 · Cited by 56
Self-citationMAP kinase regulation of IP10/CXCL10 chemokine gene expression in microglial cells
Shen, Q., Zhang, R., & Bhat, N. R. (2006) · Brain Research · doi:10.1016/j.brainres.2006.02.116 · Cited by 56
Chakravarty, S. D., Xu, J., Lu, B., Gerard, C. J., Flynn, J. L., & Chan, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1723 · Cited by 56
Uicker, W. C., Doyle, H. A., McCracken, J. P., Langlois, M., & Buchanan, K. L. (2004) · Medical Mycology · doi:10.1080/13693780410001731510 · Cited by 56
Road signs guiding leukocytes along the inflammation superhighway
Bochner, B. S. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.110813 · Cited by 56
Lung transplantation: infection, inflammation, and the microbiome
Nakajima, T., Palchevsky, V., Perkins, D. L., Belperio, J. A., & Finn, P. W. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0249-9 · Cited by 57
Wickham, S., Lu, B., Ash, J. D., & Carr, D. J. J. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.01.001 · Cited by 55
Chikungunya virus: recent advances in epidemiology, host pathogen interaction and vaccine strategies
Deeba, F., Islam, A., Kazim, S. N., Naqvi, I. H., Broor, S., Ahmed, A., & Parveen, S. (2015) · Pathogens and Disease · doi:10.1093/femspd/ftv119 · Cited by 55
Chikungunya Virus-Induced Arthritis: Role of Host and Viral Factors in the Pathogenesis
Amdekar, S., Parashar, D., & Alagarasu, K. (2017) · Viral Immunology · doi:10.1089/vim.2017.0052 · Cited by 55
Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors
Refae, S., Gal, J., Ebran, N., Otto, J., Borchiellini, D., Peyrade, F., Chamorey, E., Brest, P., Milano, G. A., & Saâda-Bouzid, E. (2019) · Investigational New Drugs · doi:10.1007/s10637-019-00845-w · Cited by 56
CXCR3-binding chemokines in multiple myeloma
Pellegrino, A. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.10.036 · Cited by 55
Rottman, J. B. (1999) · Veterinary Pathology · doi:10.1354/vp.36-5-357 · Cited by 55
Self-citationSuzaki, Y., Hamada, K., Nomi, T., Ito, T., Sho, M., Kai, Y., Nakajima, Y., & Kimura, H. (2007) · European Respiratory Journal · doi:10.1183/09031936.00111507 · Cited by 55
Fujiki, F., Oka, Y., Tsuboi, A., Kawakami, M., Kawakatsu, M., Nakajima, H., Elisseeva, O. A., Harada, Y., Ito, K., Li, Z., et al. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/01.cji.0000211337.91513.94 · Cited by 55
Thapa, M., & Carr, D. J. J. (2009) · Journal of Virology · doi:10.1128/jvi.00854-09 · Cited by 54
CCR5 Deficiency Aggravates Crescentic Glomerulonephritis in Mice
Turner, J., Paust, H., Steinmetz, O. M., Peters, A., Meyer‐Schwesinger, C., Heymann, F., Helmchen, U. M., Fehr, S., Horuk, R., Wenzel, U. O., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6546 · Cited by 55
T Follicular Helper-Like Cells in Inflamed Non-Lymphoid Tissues
Hutloff, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01707 · Cited by 56
Szekanecz, Z., & Koch, A. E. (2001) · Current Rheumatology Reports · doi:10.1007/s11926-001-0051-0 · Cited by 54
Self-citationCharacterization of Effusion-Infiltrating T Cells
Atanackovic, D., Block, A., de Weerth, A., Faltz, C., HOSSFELD, D. K., & Hegewisch‐Becker, S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0239 · Cited by 54
Kitani, A., Nakashima, N., Izumihara, T., Inagaki, M., Xu, B., Yu, S., Matsuda, T., & Matsuyama, T. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4931 · Cited by 54
Buckner, L. R., Lewis, M. E., Greene, S. J., Foster, T. P., & Quayle, A. J. (2013) · Cytokine · doi:10.1016/j.cyto.2013.04.022 · Cited by 53
Mpande, C. A. M., Dintwe, O., Musvosvi, M., Mabwe, S., Bilek, N., Hatherill, M., Nemes, E., & Scriba, T. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00324 · Cited by 54
Chemokine production during hypersensitivity pneumonitis
Nance, S. C., Cross, R. J., & Fitzpatrick, E. A. (2004) · European Journal of Immunology · doi:10.1002/eji.200324634 · Cited by 53
Adhesion of lymphocytes to hepatic endothelium.
Lalor, P. F., & Adams, D. (1999) · Molecular Pathology · doi:10.1136/mp.52.4.214 · Cited by 53
Heydtmann, M., Hardie, D. L., Shields, P. L., Faint, J., Buckley, C. D., Campbell, J. J., Salmon, M., & Adams, D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.729 · Cited by 54
Clinical overview of leukocyte adhesion and migration: where are we now?
Marshall, D., & Haskard, D. O. (2002) · Seminars in Immunology · doi:10.1006/smim.2001.0350 · Cited by 53
Evaluation of the effect of GM-CSF blocking on the phenotype and function of human monocytes
Lotfi, N., Zhang, G., Esmaeil, N., & Rostami, A. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-58131-2 · Cited by 52
Immunoregulation of a CB2 Receptor Agonist in a Murine Model of NeuroAIDS
Gorantla, S., Makarov, E., Roy, D., Finke-Dwyer, J., Murrin, L. C., Gendelman, H. E., & Poluektova, L. Y. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9225-8 · Cited by 53
Both Th1 and Th2 chemokines are elevated in sera of patients with autoimmune blistering diseases
Echigo, T., Hasegawa, M., Shimada, Y., Inaoki, M., Takehara, K., & Sato, S. (2006) · Archives of Dermatological Research · doi:10.1007/s00403-006-0661-5 · Cited by 52
Neutralizing Nanobodies Targeting Diverse Chemokines Effectively Inhibit Chemokine Function
Blanchetot, C., Verzijl, D., Mujić-Delić, A., Bosch, L., Rem, L., Leurs, R., Verrips, C. T., Saunders, M. J., de Haard, H., & Smit, M. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.467969 · Cited by 52
Dabee, S., Barnabas, S. L., Lennard, K. S., Jaumdally, S. Z., Gamieldien, H., Balle, C., Happel, A., Murugan, B. D., Williamson, A., Mkhize, N. N., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213975 · Cited by 52
Méndez, R., Ruiz‐Cabello, F., Rodríguez, T., Campo, A. D., Paschen, A., Schadendorf, D., & Garrido, F. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0166-2 · Cited by 52
Chemokine RANTES in gingival crevicular fluid of adult patients with periodontitis
Gamonal, J. A., Bascones, A., Jorge, O., & Silva, A. H. L. (2000) · Journal Of Clinical Periodontology · doi:10.1034/j.1600-051x.2000.027009675.x · Cited by 52
You, C. R., Park, S., Jeong, S. W., Woo, H. Y., Bae, S. H., Choi, J. Y., Sung, Y. C., & Yoon, S. K. (2011) · Gut and Liver · doi:10.5009/gnl.2011.5.4.506 · Cited by 51
Gerstner, C., Turcinov, S., Hensvold, A. H., Chemin, K., Uchtenhagen, H., Ramwadhdoebé, T. H., Dubnovitsky, A. P., Kozhukh, G., Rönnblom, L., Kwok, W. W., et al. (2020) · BMC Immunology · doi:10.1186/s12865-020-00357-w · Cited by 51
Dar, W. A., & Knechtle, S. J. (2007) · Immunology · doi:10.1111/j.1365-2567.2006.02534.x · Cited by 51
Molecular mechanisms of immunity in corneal allotransplantation and xenotransplantation
Qian, Y., & Dana, M. R. (2001) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399401003246 · Cited by 51
Chemokines as novel therapeutic targets in inflammatory diseases
Ajuebor, M. N., Swain, M. G., & Perretti, M. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00854-7 · Cited by 51
Hwang, S., Choi, Y. G., Jeong, M., Hong, Y., Lee, J.-H., & Lim, S. (2009) · Gene · doi:10.1016/j.gene.2009.04.024 · Cited by 50
Battaglia, A., Buzzonetti, A., Martinelli, E., Fanelli, M., Petrillo, M., Ferrandina, G., Scambia, G., & Fattorossi, A. (2010) · International Journal of Radiation Oncology, Biology, Physics · doi:10.1016/j.ijrobp.2009.10.014 · Cited by 50
Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma
Gebauer, F., Tachezy, M., Effenberger, K. E., von Loga, K., Zander, H., Marx, A., Kaifi, J. T., Sauter, G., Izbicki, J. R., & Bockhorn, M. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21957 · Cited by 50
Dysregulation of CD4 + T Cell Subsets in Intracranial Aneurysm
Zhang, H., Zhao, M., Liang, G., Yu, C., He, W., Li, Z., & Gao, X. (2015) · DNA and Cell Biology · doi:10.1089/dna.2015.3105 · Cited by 50
Vanpouille, C., Introini, A., Morris, S., Margolis, L. B., Daar, E. S., Dubé, M. P., Little, S. J., Smith, D. M., Lisco, A., & Gianella, S. (2015) · AIDS · doi:10.1097/qad.0000000000000964 · Cited by 50
Su, Y.-C., Rolph, M. S., Hansbro, N. G., Mackay, C. R., & Sewell, W. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2600 · Cited by 50
Self-citationYu, B., Koga, T., Urabe, K., Moroi, Y., Maeda, S., Yanagihara, Y., & Furue, M. (2002) · Journal of Dermatological Science · doi:10.1016/s0923-1811(02)00046-4 · Cited by 50
Howard, O. M. Z., Dong, H., Su, S. B., Caspi, R. R., Chen, X., Plötz, P. H., & Oppenheim, J. J. (2005) · Blood · doi:10.1182/blood-2004-07-2697 · Cited by 50
Hart, M., Nickl, L., Walch‐Rückheim, B., Krammes, L., Rheinheimer, S., Diener, C., Tänzer, T., Kehl, T., Sester, M., Lenhof, H., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001617 · Cited by 49
Pharmacological characterization of a small‐molecule agonist for the chemokine receptor CXCR3
Scholten, D. J., Canals, M., Wijtmans, M., de Munnik, S., Nguyen, P., Verzijl, D., de Esch, I. J. P., Vischer, H. F., Smit, M. J., & Leurs, R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01648.x · Cited by 49
Thompson, S. D., Luyrink, L. K., Graham, T. B., Tsoras, M., Ryan, M. H., Passo, M. H., & Glass, D. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6899 · Cited by 49
Sellati, T. J., Waldrop, S. L., Salazar, J. C., Bergstresser, P. R., Picker, L. J., & Radolf, J. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4131 · Cited by 49
Singh, U. P., Singh, S., Singh, R., Cong, Y., Taub, D. D., & Lillard, J. W. (2008) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2007.0059 · Cited by 49
Chemokine expression in Th1 cell-induced lung injury: prominence of IFN-γ-inducible chemokines
Dixon, A. E., Mandac, J. B., Madtes, D. K., Martin, P. J., & Clark, J. G. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.3.l592 · Cited by 49
Chagas disease: Immunology of the disease at a glance
Silva, A. C. C., de Castro, M. C. A. B., Hernandes, M. Z., & Pereira, V. R. A. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.10.001 · Cited by 48
Mahad, D., Lawry, J., Howell, S. J., & Woodroofe, M. N. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms899oa · Cited by 48
Yoshino, O., Osuga, Y., Koga, K., Hirota, Y., Tsutsumi, O., Yano, T., Morita, Y., Momoeda, M., Fujiwara, T., Kugu, K., et al. (2003) · American Journal of Reproductive Immunology · doi:10.1034/j.1600-0897.2003.00037.x · Cited by 48
Selective accumulation of CCR4+ T lymphocytes into renal tissue of patients with lupus nephritis
Yamada, M., Yagita∥, H., Inoue, H., Takanashi, T., Matsuda, H., Munechika, E., Kanamaru, Y., Shirato, I., Tomino, Y., Matushima, K., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10112 · Cited by 48
Serum chemokine profiles in patients with alopecia areata
Kuwano, Y., Fujimoto, M., Watanabe, R., Ishiura, N., Nakashima, H., Ohno, Y., Yano, S., Yazawa, N., Okochi, H., & Tamaki, K. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07943.x · Cited by 47
Dobrzanski, M. J., Reome, J. B., & Dutton, R. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.424 · Cited by 47
Jinquan, T., Sha, Q., Jacobi, H. H., Chen, J., Millner, A. H., Jensen, B. M., MADSEN, H. O., Ryder, L. P., Svejgaard, A., Malling, H., et al. (2000) · Blood · doi:10.1182/blood.v96.4.1230 · Cited by 47
Yang, Y., Tomura, M., 岩崎, 正., Mukai, T., Gao, P., Ono, S., Zou, J.-P., Shearer, G. M., Fujiwara, H., & Hamaoka, T. (2001) · Journal of Clinical Immunology · doi:10.1023/a:1011059906777 · Cited by 47
Fukushima, A., Ozaki, A., Fukata, K., Ishida, W., & Ueno, H. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1323 · Cited by 47
Heer, A. K., Harris, N. L., Köpf, M., & Marsland, B. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.6984 · Cited by 46
Takebe, K., Rai, M. F., Schmidt, E. J., & Sandell, L. J. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.12.002 · Cited by 46
Regulation of CXCL9/10/11 in Oral Keratinocytes and Fibroblasts
Ohta, K., Shigeishi, H., Taki, M., Nishi, H., Higashikawa, K., Takechi, M., & Kamata, N. (2008) · Journal of Dental Research · doi:10.1177/154405910808701211 · Cited by 46
Francis, L., Guo, Z. S., Liu, Z., Ravindranathan, R., Urban, J. A., Sathaiah, M., Magge, D. R., Kaliński, P., & Bartlett, D. L. (2016) · Oncotarget · doi:10.18632/oncotarget.7907 · Cited by 46
Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies
Derhovanessian, A., Wallace, W. D., Lynch, J. P., Belperio, J. A., & WEIGT, S. S. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1618567 · Cited by 48
Kung, C.-C., Dai, S.-P., Chiang, H., Huang, H., & Sun, W. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05422-6 · Cited by 46
Therapeutic inhibition of leukocyte recruitment in inflammatory diseases
Szekanecz, Z. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.03.013 · Cited by 46
Expression Pattern of CXCR3, CXCR4, and CCR3 Chemokine Receptors in the Developing Human Brain
van der Meer, P., Goldberg, S. H., Fung, K. M., Sharer, L. R., González‐Scarano, F., & Lavi, E. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.1.25 · Cited by 46
Therapeutic applications in the chemokine superfamily
Houshmand, P., & Zlotnik, A. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00086-3 · Cited by 46
Rieper, C. D. L., Christensen, J. E., Nansen, A., Moos, T., Lu, B., Gerard, C. J., Christensen, J. P., & Thomsen, A. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1767 · Cited by 46
Dagan‐Berger, M., Feniger-Barish, R., Avniel, S., Wald, H., Galun, E., Grabovsky, V., Alon, R., Nagler, A., Ben‐Baruch, A., & Peled, A. (2005) · Blood · doi:10.1182/blood-2004-01-0214 · Cited by 45
Zaunders, J. J., Kaufmann, G. R., Cunningham, P., Smith, D. E., Grey, P., Suzuki, K., Carr, A. D., Goh, L., & Cooper, D. A. (2001) · The Journal of Infectious Diseases · doi:10.1086/318827 · Cited by 45
Metadata
- Authors
- Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R.
- Affiliations
- Brigham and Women's Hospital (US)
- University of Bern (CH)
- Northwestern University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1998-02-15
- Volume
- 101
- Issue
- 4
- Pages
- 746-754
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508621
- OpenAlex
- W2081596482
- Cited by
- 1,359
- References
- 39
- Citations by year
- 2026: 6 · 2025: 25 · 2024: 11 · 2023: 20 · 2022: 24 · 2021: 33 · 2020: 23 · 2019: 33 · 2018: 32 · 2017: 33 · 2016: 24 · 2015: 46 · 2014: 52 · 2013: 38 · 2012: 45
- FWCI
- 37.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Immunology and Microbiology › Immunology › Macrophage Migration Inhibitory Factor
- Keywords
- CXCR3, CCR5, chemokine receptors, T cell subsets, T cell homing, inflammatory cell infiltration, Th1 response, CXCL10, RANTES, CCL22, CCL19, CD45RO, beta1 integrin, T cell migration, lymph node T cells
- MeSH terms
- Animals, Antibodies, Monoclonal, Chemotaxis, Humans, Immunologic Memory, Inflammation, Leukocytes, Lymphocyte Activation, Lymphocytes, Mice, Inbred BALB C, Synovial Fluid, Tumor Cells, Cultured, Biomarkers, T-Lymphocyte Subsets, Chemokines, Receptors, Chemokine, Receptors, CCR5, Chemokines, CXC, Mice, Chemokine CXCL10, Receptors, CXCR3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review